NAS:GRTS (USA) Also Trade In: Germany
Gritstone Oncology Inc $ 13.87 0.3 (2.21%)
Warning! GuruFocus has detected 1 Severe warning sign with GRTS. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Gritstone Oncology Inc () from 2018 to Mar 08 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Gritstone Oncology stock (GRTS) PE ratio as of Mar 08 2021 is 0. More Details
Gritstone Oncology PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Gritstone Oncology PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:ABEO NAS:SPRO NAS:ADMA NAS:ADRO NAS:LQDA NAS:FBIO OTCPK:NWBO NAS:NYMX NYSE:RFL NAS:PRQR OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Address 5959 Horton Street, Suite 300, Emeryville, CA, USA, 94608
Gritstone Oncology Inc is a United States based immune-oncology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors including GRANITE-001 and SLATE-001.